免疫检查点阻断通过扩增效应 CD8⁺ T 细胞克隆增强淋巴细胞清除性化疗诱导的抗肿瘤免疫
Immune Checkpoint Blockade Augments Lymphodepleting Chemotherapy-Induced Antitumor Immunity by Expanding Effector CD8+ T-cell Clones.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Efficacy of treatment with tumor-infiltrating lymphocytes as adoptive cell therapy: an integrative review.
Efficacy of treatment with tumor-infiltrating lymphocytes as adoptive cell therapy: an integrative review.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
本综述表明,使用 TIL(肿瘤浸润淋巴细胞)的过继性细胞疗法显示出疗效,尤其是在转移性黑色素瘤的治疗中,并在治疗实体瘤方面展现出相当大的前景。
本综述文章探讨了使用TIL(肿瘤浸润淋巴细胞)的过继细胞疗法的疗效,特别关注黑色素瘤和其他实体瘤的治疗。
方法学包括主题定义、全面的数据库检索以及对相关文献的批判性综述。在最初识别的1,947篇文章中,根据严格的纳入和排除标准,精心筛选出15篇。
研究结果表明,基于TIL(肿瘤浸润淋巴细胞)的疗法在治疗转移性黑色素瘤方面特别有效,其定制化方法和巨大潜力已得到证实。然而,这些发现对其他实体瘤类型的适用性仍然有限。
This integrative review article examines the efficacy of adoptive cell therapy using tumor-infiltrating lymphocytes, with a particular focus on the treatment of melanomas and other solid tumors.
The methodology encompasses theme definition, comprehensive database searches, and a critical review of pertinent literature. Of the 1,947 articles initially identified, 15 were meticulously selected based on stringent inclusion and exclusion criteria.
The findings suggest that tumor-infiltrating lymphocytes-based therapy is particularly effective in treating metastatic melanomas, as noted by its tailored approach and substantial potential. However, the applicability of these findings to other solid tumor types remains limited.
This review indicates that adoptive cell therapy using tumor-infiltrating lymphocytes demonstrates efficacy, especially in the treatment of metastatic melanoma, and shows considerable promise for treating solid tumors.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。